Search
Study opens up possibility of bespoke prostate cancer treatment
The knowledge could reduce the risk of severe bowel complications from radiotherapy, heralding a more personalized approach to prostate cancer treatment
Thermo Fisher Scientific launches Chromeleon 7.4 software
Chromeleon™ 7.4 unifies chromatography and MS data in one streamlined, scalable platform – enabling remote access, centralized storage, full traceability, and automated compliance features for labs in biopharma, food safety, and environmental testing
Shifting towards scalable cancer diagnostics with AI enabled companion diagnostic solutions
SVP Karan Arora shares how advanced assays, AI, and pharma partnerships are shaping the future of targeted oncology care
Accelerating your journey to the clinic
TimePix 4 for imaging
InertSep Oligo SPE
Advancing Biomedical Science in Africa with Frank Sandulu
Championing biomedical science, combating antimicrobial resistance, and inspiring future generations in Africa
Aptamer expands into targeted radiopharmaceuticals with major top 3 pharma contract
Development agreement applies Optimer binders to cancer imaging and therapeutics
Association for Molecular Pathology develops standardized biomarker report template for providers
Joint consensus recommendation includes organizational representation from AMP, ASCO and CAP
Roche receives CE mark for AI-based kidney Klinrisk agorithm
This tool will be launched as part of Roche’s new chronic kidney disease algorithm panel to support care across the stages of the disease which affects 700 million people globally
Cytomegalovirus: The role of antibodies in advancing CMV diagnostics
On-site sugar content analysis in cereal
On-site milk analysis with ProxiScout
Alithea Genomics introduces extraction-free, RNA-seq for 3D drug screening and toxicology
The MERCURIUS™ Spheroid DRUG-seq is a novel, extraction-free RNA sequencing library preparation kit built for 3D spheroid models
Complex lipid analysis challenges solved with bio-inert HPLC columns
From sample limitations to isomeric separations, see how the right column choice transformed a challenging lipidomics project
Fluidic Sciences acquires business and assets of Sphere Bio
Combined portfolio unites Fluidic Sciences’ in‑solution microfluidic diffusional sizing technology with Sphere Bio’s proprietary picodroplet-microfluidic platforms, Cyto‑Mine Chroma, and high‑throughput assays – delivering end‑to‑end insight from cells to molecules
























